KindlyMD (NASDAQ:NAKA) CEO David Bailey Acquires 31,500 Shares

KindlyMD, Inc. (NASDAQ:NAKA) CEO David Bailey purchased 31,500 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were purchased at an average cost of $5.58 per share, with a total value of $175,770.00. Following the acquisition, the chief executive officer owned 3,015,528 shares in the company, valued at $16,826,646.24. This trade represents a 1.06% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.

KindlyMD Trading Down 1.6%

Shares of KindlyMD stock opened at $5.40 on Thursday. The company has a 50 day moving average of $8.31 and a 200-day moving average of $13.24. KindlyMD, Inc. has a 1-year low of $4.50 and a 1-year high of $1,120.00. The company has a market cap of $93.98 million, a PE ratio of -0.13 and a beta of 17.12.

KindlyMD (NASDAQ:NAKA) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($15.20) earnings per share for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%.The firm had revenue of $2.68 million for the quarter. Research analysts forecast that KindlyMD, Inc. will post -16.8 earnings per share for the current year.

Hedge Funds Weigh In On KindlyMD

Several institutional investors and hedge funds have recently added to or reduced their stakes in NAKA. Geode Capital Management LLC increased its position in KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after acquiring an additional 8,386 shares during the period. Osaic Holdings Inc. acquired a new position in KindlyMD in the 2nd quarter valued at approximately $215,000. Truist Financial Corp acquired a new stake in shares of KindlyMD during the third quarter worth $12,470,000. Correct Capital Wealth Management acquired a new stake in shares of KindlyMD during the third quarter worth $111,339,000. Finally, RFG Advisory LLC acquired a new stake in shares of KindlyMD during the third quarter worth $1,019,000.

Wall Street Analysts Forecast Growth

NAKA has been the subject of a number of research analyst reports. Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a research report on Saturday, May 23rd. B. Riley Financial lowered their price objective on shares of KindlyMD from $40.00 to $20.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. Weiss Ratings upgraded shares of KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. Maxim Group lowered their price objective on shares of KindlyMD from $60.00 to $30.00 and set a “buy” rating for the company in a research report on Monday, April 6th. Finally, TD Cowen initiated coverage on shares of KindlyMD in a research report on Friday, April 10th. They set a “buy” rating and a $40.00 price objective for the company. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $30.00.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.